NYSE:BHC - Bausch Health Companies Stock Price Target and Predictions

Target and Analyst Ratings
Price Target History
Upgrades and Downgrades
About
FAQ

Consensus Rating: Hold
Consensus Price Target: $34.80
Forecasted Upside: 16.35 %
Number of Analysts: 9
Breakdown:
1 Sell Ratings
3 Hold Ratings
5 Buy Ratings
0 Strong Buy Ratings

^$29.91 As of 06/16/2021 01:00 AM ET

▼ -0.98 (-3.17%)

1 month | 3 months | 12 months

Get New Bausch Health Companies Analyst Ratings Delivered To Your Inbox

Sign-up to receive the latest news and ratings for BHC and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for BHC

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

^$34.80

▲ +16.35% Upside Potential

This price target is based on 9 analysts offering 12 month price targets for Bausch Health Companies in the last 3 months. The average price target is $34.80, with a high forecast of $55.00 and a low forecast of $17.00. The average price target represents a 16.35% upside from the last price of $29.91.

Hold

The current consensus among 9 contributing investment analysts is to hold stock in Bausch Health Companies. This rating has held steady since April 2021, when it changed from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

0 strong buy ratings
11 buy ratings
2 hold ratings
1 sell ratings

Ratings as of

12/24/2019

0 strong buy ratings
11 buy ratings
3 hold ratings
0 sell ratings

Ratings as of

3/23/2020

0 strong buy ratings
11 buy ratings
4 hold ratings
0 sell ratings

Ratings as of

6/21/2020

0 strong buy ratings
10 buy ratings
5 hold ratings
1 sell ratings

Ratings as of

9/19/2020

0 strong buy ratings
9 buy ratings
4 hold ratings
1 sell ratings

Ratings as of

12/18/2020

0 strong buy ratings
7 buy ratings
4 hold ratings
1 sell ratings

Ratings as of

3/18/2021

0 strong buy ratings
5 buy ratings
3 hold ratings
1 sell ratings

Ratings as of

5/17/2021

0 strong buy ratings
5 buy ratings
3 hold ratings
1 sell ratings

Ratings as of

6/16/2021

Latest Recommendations

Show Most Recent Rating from Each Ratings Firm Show All Ratings

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price	Details
5/5/2021	Royal Bank of Canada	Lower Price Target	Outperform	$42.00 ➝ $41.00	Low	i
3/30/2021	Bank of America	Reiterated Rating	Neutral ➝ Underperform	$27.00	Low	i
3/24/2021	Bank of America	Downgrade	Neutral ➝ Underperform	$27.00	Low	i
3/16/2021	HC Wainwright	Boost Price Target	Buy	$50.00 ➝ $55.00	Low	i
3/14/2021	JPMorgan Chase & Co.	Reiterated Rating	Buy	$38.00	Low	i
3/2/2021	Citigroup	Boost Price Target		$32.00 ➝ $37.00	Low	i
2/26/2021	Morgan Stanley	Boost Price Target	Equal Weight	$22.00 ➝ $35.00	Medium	i
2/25/2021	Barclays	Boost Price Target	Overweight	$27.00 ➝ $35.00	Low	i
2/17/2021	Royal Bank of Canada	Upgrade	Sector Perform ➝ Outperform	$26.00 ➝ $42.00	Low	i
2/16/2021	JPMorgan Chase & Co.	Boost Price Target	Overweight	$32.00 ➝ $38.00	Low	i
1/22/2021	Piper Sandler	Downgrade	Overweight ➝ Neutral	$25.00 ➝ $30.00	Low	i
1/15/2021	Jefferies Financial Group	Boost Price Target		$27.00 ➝ $33.00	Low	i
11/5/2020	Piper Sandler	Lower Price Target	Overweight	$26.00 ➝ $25.00	Low	i
10/28/2020	Wells Fargo & Company	Lower Price Target	Equal Weight	$18.00 ➝ $17.00	Medium	i
10/26/2020	Barclays	Boost Price Target	Overweight	$28.00 ➝ $29.00	High	i
9/17/2020	Bank of America	Upgrade	Underperform ➝ Neutral	$19.00	High	i
8/24/2020	HC Wainwright	Reiterated Rating	Buy	$64.00 ➝ $50.00	High	i Rating by Ram Selvaraju at HC Wainwright
8/19/2020	Piper Sandler	Lower Price Target	Overweight	$32.00 ➝ $26.00	High	i
8/10/2020	Royal Bank of Canada	Boost Price Target	Sector Perform	$23.00 ➝ $26.00	Low	i
8/10/2020	Citigroup	Lower Price Target	Buy	$27.00 ➝ $26.00	Medium	i
8/7/2020	Barclays	Boost Price Target	Overweight	$25.00 ➝ $28.00	High	i
7/31/2020	Royal Bank of Canada	Lower Price Target	Sector Perform	$24.00 ➝ $23.00	Low	i
7/7/2020	Bank of America	Boost Price Target	Underperform	$12.00 ➝ $14.00	High	i
6/17/2020	HC Wainwright	Boost Price Target	Buy	$50.00 ➝ $64.00	Medium	i Rating by Ram Selvaraju at HC Wainwright
5/8/2020	Cfra	Lower Price Target	Hold	$28.00 ➝ $18.00	Low	i
5/8/2020	SunTrust Banks	Lower Price Target	Buy	$25.00 ➝ $24.00	High	i
5/8/2020	Royal Bank of Canada	Lower Price Target	Sector Perform	$25.00 ➝ $24.00	High	i
4/30/2020	Wells Fargo & Company	Boost Price Target	Equal Weight	$17.00 ➝ $18.00	Low	i Rating by David Maris at Wells Fargo & Company
4/28/2020	HC Wainwright	Reiterated Rating	Buy	$50.00	Medium	i Rating by Ram Selvaraju at HC Wainwright
4/28/2020	Royal Bank of Canada	Lower Price Target	Sector Perform	$26.00 ➝ $25.00	High	i
4/24/2020	Citigroup	Initiated Coverage	Buy	$30.00	High	i
4/23/2020	Jefferies Financial Group	Lower Price Target	Buy	$35.00 ➝ $27.00	Medium	i
4/2/2020	Morgan Stanley	Downgrade	Overweight ➝ Equal Weight		Low	i
3/23/2020	HC Wainwright	Lower Price Target	Buy	$60.00 ➝ $50.00	High	i Rating by Ram Selvaraju at HC Wainwright
3/23/2020	Wells Fargo & Company	Lower Price Target	Equal Weight	$32.00 ➝ $17.00	High	i Rating by David Maris at Wells Fargo & Company
3/17/2020	Royal Bank of Canada	Lower Price Target	Sector Perform	$31.00 ➝ $26.00	Medium	i
2/20/2020	Royal Bank of Canada	Lower Price Target	Sector Perform	$33.00 ➝ $31.00	High	i
2/20/2020	SunTrust Banks	Lower Price Target	Buy	$32.00 ➝ $31.00	Low	i
2/19/2020	Cowen	Reiterated Rating	Buy	$40.00	Low	i Rating by Ken Cacciatore at Cowen Inc
2/19/2020	Guggenheim	Reiterated Rating	Buy	$36.00	Low	i Rating by Dana Flanders at Guggenheim
2/11/2020	Morgan Stanley	Lower Price Target	Overweight	$34.00 ➝ $32.00	Low	i
2/4/2020	Royal Bank of Canada	Boost Price Target	Sector Perform	$31.00 ➝ $33.00	High	i
1/29/2020	Wolfe Research	Downgrade	Outperform ➝ Peer Perform		Low	i
1/26/2020	Barclays	Reiterated Rating	Buy	$33.00	Low	i
1/22/2020	Wells Fargo & Company	Upgrade	Underweight ➝ Equal Weight	$32.00	Medium	i Rating by David Maris at Wells Fargo & Company
12/30/2019	Piper Jaffray Companies	Boost Price Target	Neutral ➝ Overweight	$30.00 ➝ $39.00	Medium	i
12/23/2019	HC Wainwright	Reiterated Rating	Buy	$60.00	N/A	i Rating by Ram Selvaraju at HC Wainwright
12/12/2019	JPMorgan Chase & Co.	Upgrade	Neutral ➝ Overweight	$32.00 ➝ $38.00	High	i
12/2/2019	HC Wainwright	Reiterated Rating	Buy	$54.00 ➝ $60.00	Low	i
12/2/2019	The Goldman Sachs Group	Initiated Coverage	Neutral	$30.00	Low	i
11/5/2019	Barclays	Boost Price Target	Overweight	$28.00 ➝ $30.00	Low	i Rating by Balaji Prasad at Barclays PLC
10/25/2019	Cowen	Initiated Coverage	Outperform	$35.00	Medium	i
9/17/2019	Wells Fargo & Company	Reiterated Rating	Sell		Low	i Rating by David Maris at Wells Fargo & Company
9/12/2019	Guggenheim	Initiated Coverage	Buy	$30.00	High	i
8/15/2019	TD Securities	Upgrade	Hold ➝ Buy	$28.00	Medium	i
8/7/2019	HC Wainwright	Boost Price Target	Market Perform ➝ Buy	$50.00 ➝ $54.00	Low	i
7/29/2019	HC Wainwright	Lower Price Target	Buy	$58.00 ➝ $50.00	Low	i
7/19/2019	Wolfe Research	Initiated Coverage	Outperform ➝ Outperform	$31.00	Low	i
7/15/2019	Wells Fargo & Company	Reiterated Rating	Sell		Low	i Rating by David Maris at Wells Fargo & Company
7/8/2019	Barclays	Set Price Target	Buy	$28.00	Low	i Rating by Balaji Prasad at Barclays PLC
6/20/2019	Mizuho	Set Price Target	Buy	$45.00	Medium	i Rating by Irina Rivkind Koffler at Mizuho
6/11/2019	Piper Jaffray Companies	Set Price Target	Buy	$29.00	Medium	i Rating by David Amsellem at Piper Jaffray Companies
6/11/2019	Barclays	Reiterated Rating	Overweight ➝ Overweight	$28.00	Medium	i
5/31/2019	Cantor Fitzgerald	Set Price Target	Buy	$32.00	Low	i Rating by Louise Chen at Cantor Fitzgerald
5/17/2019	Wells Fargo & Company	Set Price Target	Sell	$9.00	Low	i Rating by David Maris at Wells Fargo & Company
5/13/2019	JPMorgan Chase & Co.	Upgrade	Underweight ➝ Neutral	$24.80	Low	i
5/7/2019	Mizuho	Boost Price Target	Buy	$41.00 ➝ $45.00	Low	i
4/25/2019	Cantor Fitzgerald	Reiterated Rating	Buy	$32.00	Low	i
4/2/2019	Piper Jaffray Companies	Set Price Target	Buy	$28.00	Low	i Rating by David Amsellem at Piper Jaffray Companies
3/20/2019	Bank of America	Reiterated Rating	Underperform	$18.00	High	i
3/19/2019	SunTrust Banks	Initiated Coverage	Buy ➝ Buy	$30.00	High	i
3/18/2019	Mizuho	Boost Price Target	Buy	$39.00 ➝ $41.00	High	i
2/28/2019	HC Wainwright	Reiterated Rating	Buy		Medium	i Rating by Ram Selvaraju at HC Wainwright
2/19/2019	Wells Fargo & Company	Boost Price Target	Sell ➝ Underperform	$9.00 ➝ $25.19	High	i Rating by David Maris at Wells Fargo & Company
1/6/2019	Mizuho	Reiterated Rating	Buy	$39.00	High	i
1/2/2019	UBS Group	Upgrade	Buy		High	i
1/1/2019	Piper Jaffray Companies	Upgrade	Neutral ➝ Overweight	$27.00	High	i Rating by David Amsellem at Piper Jaffray Companies
12/17/2018	Morgan Stanley	Set Price Target	Buy	$32.00	High	i Rating by David Risinger at Morgan Stanley
12/14/2018	HC Wainwright	Upgrade	Average ➝ Buy		Low	i
12/12/2018	Wells Fargo & Company	Set Price Target	Sell	$9.00	Medium	i Rating by David Maris at Wells Fargo & Company
11/30/2018	Mizuho	Boost Price Target	Buy ➝ Buy	$35.00 ➝ $38.00	Low	i
11/13/2018	BMO Capital Markets	Reiterated Rating	Hold	$26.00	Medium	i
11/7/2018	TD Securities	Boost Price Target	Hold	$24.00 ➝ $28.00	Low	i
11/7/2018	Royal Bank of Canada	Boost Price Target	Hold	$30.00 ➝ $31.00	Medium	i Rating by Douglas Miehm at Royal Bank of Canada
11/6/2018	Cantor Fitzgerald	Reiterated Rating	Buy		N/A	i Rating by Louise Chen at Cantor Fitzgerald
11/5/2018	Morgan Stanley	Upgrade	Equal Weight ➝ Overweight	$32.00	High	i Rating by David Risinger at Morgan Stanley
10/15/2018	HC Wainwright	Set Price Target	Hold	$25.00	Low	i Rating by Ram Selvaraju at HC Wainwright
10/8/2018	HC Wainwright	Set Price Target	Hold	$25.00	Medium	i Rating by Ram Selvaraju at HC Wainwright
10/8/2018	Mizuho	Reiterated Rating	Buy	$35.00	Medium	i
10/8/2018	Royal Bank of Canada	Set Price Target	Sector Perform ➝ Hold	$26.00 ➝ $30.00	Medium	i Rating by Douglas Miehm at Royal Bank of Canada
9/13/2018	HC Wainwright	Reiterated Rating	Hold	$25.00	High	i Rating by Ram Selvaraju at HC Wainwright
9/13/2018	Piper Jaffray Companies	Upgrade	Underweight ➝ Neutral	$16.00 ➝ $19.00	High	i Rating by David Amsellem at Piper Jaffray Companies
9/12/2018	Deutsche Bank Aktiengesellschaft	Set Price Target	Buy	$30.00	High	i Rating by Gregg Gilbert at Deutsche Bank Aktiengesellschaft
9/12/2018	Cantor Fitzgerald	Reiterated Rating	Buy	$32.00	High	i Rating by L. Chen at Cantor Fitzgerald
8/31/2018	HC Wainwright	Reiterated Rating	Hold	$20.00	Medium	i
8/13/2018	BMO Capital Markets	Boost Price Target	Market Perform ➝ Market Perform	$20.00 ➝ $22.00	Medium	i
8/8/2018	Royal Bank of Canada	Boost Price Target	Hold	$25.00 ➝ $26.00	Low	i Rating by Douglas Miehm at Royal Bank of Canada
8/8/2018	JPMorgan Chase & Co.	Boost Price Target	Underweight	$18.00	Low	i
8/7/2018	Piper Jaffray Companies	Set Price Target	Sell	$16.00	Low	i Rating by David Amsellem at Piper Jaffray Companies
8/7/2018	Cantor Fitzgerald	Reiterated Rating	Buy	$32.00	Low	i Rating by L. Chen at Cantor Fitzgerald
8/7/2018	Mizuho	Reiterated Rating	Buy	$31.00	High	i
8/6/2018	Wells Fargo & Company	Reiterated Rating	Sell		High	i Rating by David Maris at Wells Fargo & Company
7/23/2018	Piper Jaffray Companies	Set Price Target	Sell	$13.00	Low	i Rating by David Amsellem at Piper Jaffray Companies
6/29/2018	Deutsche Bank Aktiengesellschaft	Reiterated Rating	Buy		Low	i Rating by Gregg Gilbert at Deutsche Bank Aktiengesellschaft
6/29/2018	Mizuho	Reiterated Rating	Buy	$31.00	Medium	i
6/22/2018	TD Securities	Downgrade	Buy ➝ Hold	$24.00	Low	i Rating by Lennox Gibbs at TD Securities
6/20/2018	HC Wainwright	Reiterated Rating	Hold	$20.00	Low	i Rating by Ram Selvaraju at HC Wainwright
6/6/2018	Barclays	Upgrade	Equal Weight ➝ Overweight	$20.00 ➝ $34.00	High	i
6/5/2018	HC Wainwright	Set Price Target	Hold	$20.00	High	i Rating by Ram Selvaraju at HC Wainwright
6/1/2018	Deutsche Bank Aktiengesellschaft	Set Price Target	Buy	$25.00	Low	i Rating by Gregg Gilbert at Deutsche Bank Aktiengesellschaft
5/15/2018	Mizuho	Upgrade	Neutral ➝ Buy		Low	i
5/14/2018	Cantor Fitzgerald	Set Price Target	Buy	$25.00	Low	i Rating by Louise Chen at Cantor Fitzgerald
5/11/2018	BMO Capital Markets	Boost Price Target	Market Perform	$17.00 ➝ $20.00	Low	i
5/9/2018	BTIG Research	Reiterated Rating	Hold		Low	i Rating by Tim Chiang at BTIG Research
5/9/2018	Jefferies Financial Group	Boost Price Target	Buy	$23.00	Low	i
5/9/2018	TD Securities	Boost Price Target	Buy	$23.00 ➝ $24.00	Low	i Rating by Lennox Gibbs at TD Securities
5/9/2018	Royal Bank of Canada	Boost Price Target	Sector Perform	$18.00 ➝ $19.00	Low	i Rating by Douglas Miehm at Royal Bank of Canada
5/9/2018	JPMorgan Chase & Co.	Set Price Target	Sell	$13.00	High	i Rating by Chris Schott at JPMorgan Chase & Co.
5/9/2018	Piper Jaffray Companies	Set Price Target	Sell	$13.00	Low	i Rating by David Amsellem at Piper Jaffray Companies
5/8/2018	The Goldman Sachs Group	Set Price Target	Sell	$16.00	Medium	i Rating by Dana Flanders at The Goldman Sachs Group, Inc.
5/8/2018	Cantor Fitzgerald	Set Price Target	Buy	$25.00	High	i Rating by Louise Chen at Cantor Fitzgerald
5/7/2018	HC Wainwright	Reiterated Rating	Positive ➝ Hold	$16.00	Medium	i Rating by Ram Selvaraju at HC Wainwright
5/2/2018	Royal Bank of Canada	Set Price Target	Hold	$18.00	Medium	i Rating by Douglas Miehm at Royal Bank of Canada
4/30/2018	Deutsche Bank Aktiengesellschaft	Boost Price Target	Buy	$20.00 ➝ $22.00	Low	i Rating by Gregg Gilbert at Deutsche Bank Aktiengesellschaft
4/6/2018	Mizuho	Upgrade	Underperform ➝ Neutral	$10.00 ➝ $15.00	High	i
3/21/2018	Deutsche Bank Aktiengesellschaft	Set Price Target	Buy	$20.00	Medium	i Rating by Gregg Gilbert at Deutsche Bank Aktiengesellschaft
3/20/2018	Wells Fargo & Company	Reiterated Rating	Sell		Medium	i Rating by David Maris at Wells Fargo & Company
3/15/2018	HC Wainwright	Reiterated Rating	Hold	$16.00	Medium	i Rating by Ram Selvaraju at HC Wainwright
3/12/2018	Wells Fargo & Company	Reiterated Rating	Sell		Low	i Rating by David Maris at Wells Fargo & Company
3/5/2018	Deutsche Bank Aktiengesellschaft	Upgrade	Hold ➝ Buy	$18.00	Low	i Rating by Gregg Gilbert at Deutsche Bank Aktiengesellschaft
3/1/2018	TD Securities	Lower Price Target	Buy	$27.00 ➝ $23.00	Low	i Rating by Lennox Gibbs at TD Securities
3/1/2018	Piper Jaffray Companies	Reiterated Rating	Sell	$12.00 ➝ $10.00	High	i Rating by David Amsellem at Piper Jaffray Companies
2/28/2018	Cfra	Downgrade	Hold		High	i Rating by Jeffrey Loo at Cfra
2/28/2018	Cantor Fitzgerald	Set Price Target	Buy	$25.00	Medium	i Rating by Louise Chen at Cantor Fitzgerald
2/28/2018	Wells Fargo & Company	Reiterated Rating	Sell		Medium	i Rating by David Maris at Wells Fargo & Company
2/26/2018	HC Wainwright	Reiterated Rating	Neutral	$18.00	Low	i Rating by Ram Selvaraju at HC Wainwright
2/21/2018	Deutsche Bank Aktiengesellschaft	Set Price Target	Hold	$20.00	Low	i Rating by Gregg Gilbert at Deutsche Bank Aktiengesellschaft
1/24/2018	The Goldman Sachs Group	Initiated Coverage	Sell ➝ Sell	$18.00	High	i
1/19/2018	Cantor Fitzgerald	Set Price Target	Buy	$25.00	Medium	i Rating by Louise Chen at Cantor Fitzgerald
1/16/2018	Wells Fargo & Company	Reiterated Rating	Sell	$9.00	Low	i Rating by David Maris at Wells Fargo & Company
1/16/2018	HC Wainwright	Boost Price Target	Buy	$17.00 ➝ $24.00	High	i Rating by Ram Selvaraju at HC Wainwright
1/16/2018	HC Wainwright	Set Price Target	Hold	$17.00 ➝ $24.00	High	i Rating by Ram Selvaraju at HC Wainwright
1/5/2018	TD Securities	Boost Price Target	Buy	$20.00 ➝ $27.00	High	i
1/4/2018	Wells Fargo & Company	Reiterated Rating	Sell		Low	i Rating by David Maris at Wells Fargo & Company
1/1/2018	Cantor Fitzgerald	Set Price Target	Buy	$25.00	High	i Rating by Louise Chen at Cantor Fitzgerald
12/26/2017	Cantor Fitzgerald	Set Price Target	Buy	$25.00	Low	i Rating by Louise Chen at Cantor Fitzgerald
12/15/2017	Mizuho	Boost Price Target	Underperform ➝ Underperform	$7.00 ➝ $10.00	Medium	i
12/14/2017	JPMorgan Chase & Co.	Downgrade	Neutral ➝ Underweight	$12.00	High	i Rating by Chris Schott at JPMorgan Chase & Co.
12/3/2017	Deutsche Bank Aktiengesellschaft	Set Price Target	Hold	$18.00	Low	i Rating by Gregg Gilbert at Deutsche Bank Aktiengesellschaft
11/16/2017	Deutsche Bank Aktiengesellschaft	Set Price Target	Hold	$19.00 ➝ $18.00	N/A	i Rating by Gregg Gilbert at Deutsche Bank Aktiengesellschaft
11/13/2017	Wells Fargo & Company	Reiterated Rating	Sell		N/A	i Rating by David Maris at Wells Fargo & Company
11/13/2017	BMO Capital Markets	Boost Price Target	Market Perform	$16.00 ➝ $17.00	N/A	i
11/10/2017	Piper Jaffray Companies	Reiterated Rating	Sell	$12.00	N/A	i Rating by David Amsellem at Piper Jaffray Companies
11/9/2017	HC Wainwright	Reiterated Rating	Hold	$17.00	N/A	i Rating by Ram Selvaraju at HC Wainwright
11/8/2017	Royal Bank of Canada	Set Price Target	Sector Perform	$18.00	N/A	i Rating by Douglas Miehm at Royal Bank of Canada
11/8/2017	Deutsche Bank Aktiengesellschaft	Reiterated Rating	Hold	$19.00	N/A	i Rating by Gregg Gilbert at Deutsche Bank Aktiengesellschaft
11/7/2017	TD Securities	Upgrade	Hold ➝ Buy	$20.00	N/A	i
11/3/2017	TD Securities	Upgrade	Hold ➝ Buy	$20.00	N/A	i
11/3/2017	HC Wainwright	Reiterated Rating	Hold	$17.00	N/A	i Rating by Ram Selvaraju at HC Wainwright
10/31/2017	Cantor Fitzgerald	Set Price Target	Buy	$23.00	N/A	i Rating by Louise Chen at Cantor Fitzgerald
10/30/2017	BMO Capital Markets	Reiterated Rating	Hold	$16.00	N/A	i
10/27/2017	Wells Fargo & Company	Reiterated Rating	Sell		N/A	i Rating by David Maris at Wells Fargo & Company
10/22/2017	Piper Jaffray Companies	Set Price Target	Sell	$14.00	N/A	i Rating by David Amsellem at Piper Jaffray Companies
10/20/2017	Royal Bank of Canada	Lower Price Target	Sector Perform	$21.00 ➝ $18.00	N/A	i Rating by Joel Hurren at Royal Bank of Canada
10/9/2017	Deutsche Bank Aktiengesellschaft	Reiterated Rating	Hold	$18.00	N/A	i Rating by Gregg Gilbert at Deutsche Bank Aktiengesellschaft
10/4/2017	HC Wainwright	Reiterated Rating	Hold	$17.00	Low	i Rating by Ram Selvaraju at HC Wainwright
10/3/2017	Canaccord Genuity	Reiterated Rating	Hold	$16.00	Low	i Rating by Neil Maruoka at Canaccord Genuity
9/30/2017	Wells Fargo & Company	Reiterated Rating	Underperform	$8.00	High	i Rating by David Maris at Wells Fargo & Company
9/28/2017	Cantor Fitzgerald	Reiterated Rating	Buy	$23.00	Low	i Rating by Louise Chen at Cantor Fitzgerald
9/25/2017	Deutsche Bank Aktiengesellschaft	Reiterated Rating	Hold	$19.00	Low	i Rating by Gregg Gilbert at Deutsche Bank Aktiengesellschaft
9/18/2017	HC Wainwright	Reiterated Rating	Hold	$17.00	Low	i Rating by Ram Selvaraju at HC Wainwright
9/17/2017	Piper Jaffray Companies	Reiterated Rating	Sell	$14.00	Low	i Rating by David Amsellem at Piper Jaffray Companies
8/29/2017	Cantor Fitzgerald	Reiterated Rating	Buy	$23.00	Low	i Rating by Louise Chen at Cantor Fitzgerald
8/29/2017	Mizuho	Reiterated Rating	Sell	$8.00 ➝ $7.00	High	i
8/21/2017	Deutsche Bank Aktiengesellschaft	Set Price Target	Hold	$19.00	High	i Rating by Gregg Gilbert at Deutsche Bank Aktiengesellschaft
8/21/2017	Stifel Nicolaus	Reiterated Rating	Buy	$45.00	Medium	i
8/21/2017	HC Wainwright	Set Price Target	Hold	$17.00	Low	i Rating by Ram Selvaraju at HC Wainwright
8/16/2017	Cantor Fitzgerald	Set Price Target	Buy	$23.00	Low	i Rating by Louise Chen at Cantor Fitzgerald
8/10/2017	BMO Capital Markets	Reiterated Rating	Market Perform	$16.00	Low	i
8/10/2017	Rodman & Renshaw	Reiterated Rating	Neutral	$17.00	High	i
8/10/2017	Jefferies Financial Group	Reiterated Rating	Buy	$18.00	High	i Rating by David Steinberg at Jefferies Financial Group Inc.
8/10/2017	Stifel Nicolaus	Reiterated Rating	Buy	$35.00	Medium	i
8/10/2017	Wells Fargo & Company	Reiterated Rating	Underperform	$9.00	Medium	i Rating by David Maris at Wells Fargo & Company
8/10/2017	Canaccord Genuity	Set Price Target	Hold	$14.00	Medium	i Rating by Neil Maruoka at Canaccord Genuity
8/9/2017	Mizuho	Reiterated Rating	Underperform	$8.00	Medium	i
8/9/2017	Scotiabank	Boost Price Target	Sector Perform	$14.00 ➝ $16.00	Medium	i
8/9/2017	HC Wainwright	Set Price Target	Hold	$17.00	High	i Rating by Ram Selvaraju at HC Wainwright
8/9/2017	Piper Jaffray Companies	Set Price Target	Sell	$14.00	High	i Rating by David Amsellem at Piper Jaffray Companies
8/4/2017	Canaccord Genuity	Set Price Target	Hold	$14.00	Low	i Rating by Neil Maruoka at Canaccord Genuity
8/3/2017	Royal Bank of Canada	Boost Price Target	Sector Perform ➝ Sector Perform	$19.00 ➝ $21.00	High	i Rating by Douglas Miehm at Royal Bank of Canada
7/30/2017	Wells Fargo & Company	Dropped Coverage	Sell	$9.00	High	i Rating by David Maris at Wells Fargo & Company
7/28/2017	Cantor Fitzgerald	Set Price Target	Buy	$23.00	Low	i Rating by Louise Chen at Cantor Fitzgerald
7/27/2017	BMO Capital Markets	Reiterated Rating	Hold	$15.00	High	i
7/17/2017	JPMorgan Chase & Co.	Set Price Target	Hold	$10.00	Low	i Rating by Chris Schott at JPMorgan Chase & Co.
7/17/2017	Deutsche Bank Aktiengesellschaft	Set Price Target	Hold	$18.00 ➝ $19.00	High	i Rating by Gregg Gilbert at Deutsche Bank Aktiengesellschaft
7/17/2017	Stifel Nicolaus	Reiterated Rating	Buy	$35.00	Low	i
7/14/2017	Jefferies Financial Group	Reiterated Rating	Buy	$18.00	Low	i Rating by David Steinberg at Jefferies Financial Group Inc.
7/14/2017	Wells Fargo & Company	Reiterated Rating	Sell		Low	i Rating by David Maris at Wells Fargo & Company
7/14/2017	Piper Jaffray Companies	Reiterated Rating	Underweight	$10.00	High	i
7/12/2017	TD Securities	Boost Price Target	Hold	$15.00 ➝ $20.00	Low	i
7/6/2017	JPMorgan Chase & Co.	Reiterated Rating	Neutral	$10.00	Low	i Rating by Chris Schott at JPMorgan Chase & Co.
7/3/2017	Wells Fargo & Company	Reiterated Rating	Underperform		High	i Rating by David Maris at Wells Fargo & Company
6/30/2017	Stifel Nicolaus	Reiterated Rating	Buy	$35.00	Low	i
6/28/2017	Cantor Fitzgerald	Boost Price Target	Positive	$18.00 ➝ $23.00	High	i
6/27/2017	Wells Fargo & Company	Reiterated Rating	Sell		N/A	i Rating by David Maris at Wells Fargo & Company
6/20/2017	Mizuho	Reiterated Rating	Underperform	$8.00	Medium	i
6/19/2017	Royal Bank of Canada	Set Price Target	Sector Perform	$19.00	Medium	i Rating by Douglas Miehm at Royal Bank of Canada
6/17/2017	Guggenheim	Initiated Coverage	Buy	$18.00	High	i Rating by Louise Chen at Guggenheim
6/16/2017	Cantor Fitzgerald	Initiated Coverage	Overweight ➝ Overweight	$18.00	High	i
6/13/2017	Royal Bank of Canada	Reiterated Rating	Market Perform	$19.00	Medium	i
6/12/2017	Wells Fargo & Company	Reiterated Rating	Underperform		Medium	i Rating by David Maris at Wells Fargo & Company
6/9/2017	BMO Capital Markets	Reiterated Rating	Market Perform	$15.00	Low	i
6/8/2017	Canaccord Genuity	Set Price Target	Hold	$12.00 ➝ $14.00	High	i Rating by Neil Maruoka at Canaccord Genuity
5/23/2017	Barclays	Reiterated Rating	Hold	$20.00	Low	i
5/19/2017	Deutsche Bank Aktiengesellschaft	Set Price Target	Hold	$18.00	High	i Rating by Gregg Gilbert at Deutsche Bank Aktiengesellschaft
5/19/2017	Wells Fargo & Company	Reiterated Rating	Sell	$8.00	Medium	i Rating by David Maris at Wells Fargo & Company
5/19/2017	Rodman & Renshaw	Reiterated Rating	Neutral	$17.00	Medium	i
5/17/2017	Stifel Nicolaus	Reiterated Rating	Buy	$45.00 ➝ $35.00	Low	i
5/10/2017	HC Wainwright	Set Price Target	Hold	$17.00	Low	i Rating by Ram Selvaraju at HC Wainwright
5/10/2017	BMO Capital Markets	Reiterated Rating	Market Perform		High	i
5/10/2017	Scotiabank	Boost Price Target	Sector Perform	$12.00 ➝ $14.00	High	i
5/10/2017	TD Securities	Lower Price Target	Hold	$18.50 ➝ $15.00	High	i
5/10/2017	BTIG Research	Reiterated Rating	Neutral		Medium	i
5/10/2017	Stifel Nicolaus	Reiterated Rating	Buy	$45.00	Medium	i
5/10/2017	Barclays	Reiterated Rating	Equal Weight	$20.00	Medium	i
5/10/2017	Royal Bank of Canada	Reiterated Rating	Sector Perform ➝ Sector Perform	$18.00 ➝ $19.00	High	i
5/9/2017	JPMorgan Chase & Co.	Reiterated Rating	Hold		Medium	i Rating by Chris Schott at JPMorgan Chase & Co.
5/8/2017	Canaccord Genuity	Set Price Target	Hold	$12.00	High	i Rating by Neil Maruoka at Canaccord Genuity
5/6/2017	Jefferies Financial Group	Set Price Target	Buy	$18.00	High	i Rating by David Steinberg at Jefferies Financial Group Inc.
5/5/2017	Wells Fargo & Company	Reiterated Rating	Underperform		Low	i Rating by David Maris at Wells Fargo & Company
5/4/2017	Royal Bank of Canada	Reiterated Rating	Sector Perform	$18.00 ➝ $19.00	High	i
4/26/2017	Scotiabank	Lower Price Target	Sector Perform	$15.00 ➝ $12.00	Low	i
4/23/2017	Wells Fargo & Company	Reiterated Rating	Underperform	$11.50 ➝ $8.00	Medium	i Rating by David Maris at Wells Fargo & Company
4/20/2017	JPMorgan Chase & Co.	Lower Price Target	Neutral ➝ Neutral	$15.00 ➝ $10.00	Low	i Rating by Chris Schott at JPMorgan Chase & Co.
4/19/2017	Deutsche Bank Aktiengesellschaft	Lower Price Target	Hold	$19.00 ➝ $18.00	High	i Rating by Gregg Gilbert at Deutsche Bank Aktiengesellschaft
4/19/2017	Royal Bank of Canada	Reiterated Rating	Sector Perform	$18.00	High	i
4/17/2017	Mizuho	Reiterated Rating	Underperform	$9.00 ➝ $8.00	Low	i
4/14/2017	Piper Jaffray Companies	Reiterated Rating	Outperform	$10.00	N/A	i Rating by David Amsellem at Piper Jaffray Companies
3/23/2017	Royal Bank of Canada	Reiterated Rating	Sector Perform	$21.00 ➝ $18.00	Medium	i
3/14/2017	Canaccord Genuity	Set Price Target	Hold	$17.00 ➝ $12.00	High	i Rating by Neil Maruoka at Canaccord Genuity
3/14/2017	Wells Fargo & Company	Reiterated Rating	Underperform	$11.00 ➝ $10.00	Medium	i Rating by David Maris at Wells Fargo & Company
3/14/2017	BMO Capital Markets	Lower Price Target	Market Perform	$19.00 ➝ $15.00	Medium	i
3/11/2017	Morgan Stanley	Reiterated Rating	Equal Weight	$17.00 ➝ $12.00	N/A	i Rating by David Risinger at Morgan Stanley
3/7/2017	Deutsche Bank Aktiengesellschaft	Lower Price Target	Hold	$20.00 ➝ $19.00	N/A	i Rating by Gregg Gilbert at Deutsche Bank Aktiengesellschaft
3/6/2017	HC Wainwright	Set Price Target	Hold	$17.00	N/A	i Rating by Ram Selvaraju at HC Wainwright
3/6/2017	Mizuho	Reiterated Rating	Underperform		N/A	i
3/6/2017	Wells Fargo & Company	Reiterated Rating	Underperform	$11.50	N/A	i Rating by David Maris at Wells Fargo & Company
3/6/2017	Rodman & Renshaw	Lower Price Target	Neutral	$23.00 ➝ $17.00	N/A	i
3/3/2017	BTIG Research	Reiterated Rating	Neutral		N/A	i
3/2/2017	BMO Capital Markets	Reiterated Rating	Market Perform	$21.00 ➝ $19.00	N/A	i
3/1/2017	JPMorgan Chase & Co.	Set Price Target	Hold	$15.00	N/A	i Rating by Chris Schott at JPMorgan Chase & Co.
3/1/2017	Jefferies Financial Group	Lower Price Target	Buy	$22.00 ➝ $18.00	N/A	i Rating by David Steinberg at Jefferies Financial Group Inc.
3/1/2017	Royal Bank of Canada	Lower Price Target		$21.00	N/A	i Rating by Douglas Miehm at Royal Bank of Canada
3/1/2017	BMO Capital Markets	Boost Price Target		$21.00	N/A	i
2/28/2017	Guggenheim	Reiterated Rating	Buy	$55.00	N/A	i Rating by Louise Chen at Guggenheim
2/28/2017	HC Wainwright	Set Price Target	Hold	$23.00	N/A	i Rating by Ram Selvaraju at HC Wainwright
2/28/2017	Royal Bank of Canada	Reiterated Rating	Sector Perform	$22.00	N/A	i Rating by Douglas Miehm at Royal Bank of Canada
2/27/2017	Rodman & Renshaw	Reiterated Rating	Neutral	$23.00 ➝ $17.00	N/A	i
2/25/2017	Wells Fargo & Company	Set Price Target	Sell	$11.00	N/A	i Rating by David Maris at Wells Fargo & Company
2/23/2017	Wells Fargo & Company	Reiterated Rating	Underperform	$11.50	N/A	i Rating by david maris at Wells Fargo & Company
2/22/2017	Canaccord Genuity	Set Price Target	Hold	$19.00	N/A	i Rating by Neil Maruoka at Canaccord Genuity
2/16/2017	Wells Fargo & Company	Reiterated Rating	Underperform		N/A	i Rating by david maris at Wells Fargo & Company
2/16/2017	Mizuho	Reiterated Rating	Underperform	$11.00	N/A	i
2/14/2017	Royal Bank of Canada	Lower Price Target	Sector Perform	$29.00 ➝ $22.00	N/A	i
2/10/2017	Barclays	Lower Price Target	Equal Weight	$34.00 ➝ $20.00	N/A	i
2/9/2017	Barclays	Reiterated Rating	Hold	$34.00	N/A	i
2/9/2017	Stifel Nicolaus	Reiterated Rating	Buy	$45.00	N/A	i
2/7/2017	Guggenheim	Reiterated Rating	Buy		N/A	i Rating by Louise Chen at Guggenheim
1/31/2017	Rodman & Renshaw	Downgrade	Buy ➝ Neutral		N/A	i
1/31/2017	JPMorgan Chase & Co.	Reiterated Rating	Neutral		N/A	i
1/21/2017	Deutsche Bank Aktiengesellschaft	Set Price Target	Hold	$24.00 ➝ $20.00	N/A	i Rating by Gregg Gilbert at Deutsche Bank Aktiengesellschaft
1/21/2017	JPMorgan Chase & Co.	Reiterated Rating	Neutral		N/A	i Rating by Chris Schott at JPMorgan Chase & Co.
1/12/2017	Canaccord Genuity	Reiterated Rating	Hold	$17.00	N/A	i Rating by Neil Maruoka at Canaccord Genuity
1/11/2017	BTIG Research	Reiterated Rating	Neutral		N/A	i
1/11/2017	Wells Fargo & Company	Reiterated Rating	Underperform	$11.50	N/A	i Rating by david maris at Wells Fargo & Company
1/10/2017	Mizuho	Reiterated Rating	Underperform	$11.00	N/A	i Rating by Irina Rivkind Koffler at Mizuho
12/28/2016	Deutsche Bank Aktiengesellschaft	Reiterated Rating	Hold	$24.00	N/A	i Rating by Gregg Gilbert at Deutsche Bank Aktiengesellschaft
12/15/2016	Canaccord Genuity	Reiterated Rating	Hold	$17.00	N/A	i Rating by Neil Maruoka at Canaccord Genuity
12/15/2016	Wells Fargo & Company	Reiterated Rating	Underperform		N/A	i Rating by david maris at Wells Fargo & Company
12/15/2016	Morgan Stanley	Downgrade	Overweight ➝ Equal Weight	$25.00 ➝ $17.00	N/A	i Rating by David Risinger at Morgan Stanley
12/14/2016	Piper Jaffray Companies	Set Price Target	Sell	$16.00	N/A	i Rating by David Amsellem at Piper Jaffray Companies
12/9/2016	Mizuho	Reiterated Rating	Positive		N/A	i Rating by Irina Rivkind Koffler at Mizuho
12/4/2016	Canaccord Genuity	Reiterated Rating	Hold	$17.00	N/A	i Rating by Neil Maruoka at Canaccord Genuity
12/1/2016	Wells Fargo & Company	Reiterated Rating	Underperform	$11.50	N/A	i Rating by david maris at Wells Fargo & Company
11/29/2016	Deutsche Bank Aktiengesellschaft	Set Price Target	Hold	$24.00	N/A	i Rating by Gregg Gilbert at Deutsche Bank Aktiengesellschaft
11/23/2016	Mizuho	Downgrade	Neutral ➝ Underperform	$25.00 ➝ $11.00	N/A	i Rating by Irina Rivkind Koffler at Mizuho
11/20/2016	Deutsche Bank Aktiengesellschaft	Set Price Target	Hold	$24.00	N/A	i Rating by Gregg Gilbert at Deutsche Bank Aktiengesellschaft
11/19/2016	Canaccord Genuity	Set Price Target	Hold	$17.00	N/A	i Rating by Neil Maruoka at Canaccord Genuity
11/18/2016	Wells Fargo & Company	Reiterated Rating	Underperform	$19.50 ➝ $11.50	N/A	i Rating by david maris at Wells Fargo & Company
11/14/2016	Deutsche Bank Aktiengesellschaft	Lower Price Target	Hold	$29.00 ➝ $24.00	N/A	i Rating by Gregg Gilbert at Deutsche Bank Aktiengesellschaft
11/10/2016	Scotiabank	Reiterated Rating	Sector Perform	$32.00 ➝ $17.00	N/A	i
11/10/2016	Barclays	Reiterated Rating	Equal Weight	$34.00	N/A	i Rating by Douglas Tsao at Barclays PLC
11/10/2016	Morgan Stanley	Lower Price Target	Overweight	$42.00 ➝ $25.00	N/A	i Rating by David Risinger at Morgan Stanley
11/10/2016	Wells Fargo & Company	Reiterated Rating	Underperform	$19.50	N/A	i Rating by david maris at Wells Fargo & Company
11/10/2016	Mizuho	Reiterated Rating	Neutral	$25.00	N/A	i Rating by Irina Rivkind Koffler at Mizuho
11/10/2016	BMO Capital Markets	Reiterated Rating	Market Perform	$21.00 ➝ $29.00	N/A	i Rating by Alex Arfaei at BMO Capital Markets
11/10/2016	Rodman & Renshaw	Downgrade	Buy ➝ Neutral	$81.00 ➝ $23.00	N/A	i Rating by Ram Selvaraju at Rodman & Renshaw
11/9/2016	Jefferies Financial Group	Reiterated Rating	Buy	$40.00 ➝ $22.00	N/A	i Rating by David Steinberg at Jefferies Financial Group Inc.
11/9/2016	Canaccord Genuity	Reiterated Rating	Hold	$33.00 ➝ $17.00	N/A	i Rating by neil maruoka at Canaccord Genuity
11/9/2016	Royal Bank of Canada	Set Price Target	Sector Perform	$35.00 ➝ $29.00	N/A	i Rating by douglas miehm at Royal Bank of Canada
11/9/2016	Royal Bank of Canada	Lower Price Target	Sector Perform	$35.00 ➝ $29.00	N/A	i Rating by Douglas Miehm at Royal Bank of Canada
11/8/2016	Morgan Stanley	Set Price Target	Buy	$42.00	N/A	i Rating by David Risinger at Morgan Stanley
11/8/2016	Guggenheim	Reiterated Rating	Positive	$55.00	N/A	i
11/3/2016	Canaccord Genuity	Reiterated Rating	Hold	$33.00	N/A	i Rating by neil maruoka at Canaccord Genuity
11/3/2016	BTIG Research	Reiterated Rating	Neutral	$24.00	N/A	i
11/2/2016	Morgan Stanley	Reiterated Rating	Overweight	$42.00	N/A	i Rating by David Risinger at Morgan Stanley
11/1/2016	Scotiabank	Reiterated Rating	Sector Perform	$34.00 ➝ $32.00	N/A	i
11/1/2016	Wells Fargo & Company	Reiterated Rating	Underperform		N/A	i Rating by david maris at Wells Fargo & Company
11/1/2016	Mizuho	Reiterated Rating	Neutral	$25.00	N/A	i Rating by Irina Rivkind Koffler at Mizuho
10/26/2016	Wells Fargo & Company	Reiterated Rating	Underweight	$19.50	N/A	i Rating by david maris at Wells Fargo & Company
10/25/2016	JPMorgan Chase & Co.	Reiterated Rating	Neutral		N/A	i Rating by Chris Schott at JPMorgan Chase & Co.
10/18/2016	Wells Fargo & Company	Reiterated Rating	Underperform	$19.50	N/A	i Rating by david maris at Wells Fargo & Company
10/14/2016	Deutsche Bank Aktiengesellschaft	Lower Price Target	Hold	$30.00 ➝ $29.00	N/A	i
10/12/2016	Royal Bank of Canada	Reiterated Rating	Sector Perform	$36.00 ➝ $47.50	N/A	i Rating by douglas miehm at Royal Bank of Canada
10/12/2016	Royal Bank of Canada	Lower Price Target	Sector Perform	$36.00 ➝ $35.00	N/A	i Rating by Douglas Miehm at Royal Bank of Canada
9/30/2016	Wells Fargo & Company	Reiterated Rating	Underperform	$19.50	N/A	i Rating by david maris at Wells Fargo & Company
9/26/2016	Royal Bank of Canada	Reiterated Rating	Sector Perform	$46.00	N/A	i Rating by douglas miehm at Royal Bank of Canada
9/20/2016	Royal Bank of Canada	Reiterated Rating	Sector Perform		N/A	i Rating by douglas miehm at Royal Bank of Canada
9/20/2016	Deutsche Bank Aktiengesellschaft	Initiated Coverage	Hold	$30.00	N/A	i
9/18/2016	Wells Fargo & Company	Reiterated Rating	Sell	$19.50	N/A	i Rating by david maris at Wells Fargo & Company
9/7/2016	Royal Bank of Canada	Reiterated Rating	Sector Perform	$36.00	N/A	i Rating by douglas miehm at Royal Bank of Canada
9/7/2016	Morgan Stanley	Reiterated Rating	Overweight	$42.00	N/A	i Rating by David Risinger at Morgan Stanley
8/29/2016	Royal Bank of Canada	Reiterated Rating	Sector Perform	$36.00	N/A	i Rating by douglas miehm at Royal Bank of Canada
8/26/2016	Morgan Stanley	Reiterated Rating	Overweight	$42.00	N/A	i Rating by David Risinger at Morgan Stanley
8/22/2016	Deutsche Bank Aktiengesellschaft	Reiterated Rating	Positive		N/A	i Rating by Gregg Gilbert at Deutsche Bank Aktiengesellschaft
8/19/2016	Piper Jaffray Companies	Set Price Target	Sell	$22.00	N/A	i Rating by David Amsellem at Piper Jaffray Companies
8/19/2016	Royal Bank of Canada	Set Price Target	Hold	$36.00	N/A	i
8/19/2016	Canaccord Genuity	Reiterated Rating	Hold	$31.00 ➝ $33.00	N/A	i Rating by Neil Maruoka at Canaccord Genuity
8/19/2016	Morgan Stanley	Reiterated Rating	Positive		N/A	i Rating by David Risinger at Morgan Stanley
8/18/2016	Mizuho	Reiterated Rating	Underperform	$11.00	N/A	i Rating by Irina Rivkind Koffler at Mizuho
8/17/2016	Morgan Stanley	Upgrade	Equal Weight ➝ Overweight	$33.00 ➝ $42.00	N/A	i Rating by David Risinger at Morgan Stanley
8/16/2016	Wells Fargo & Company	Reiterated Rating	Underperform	$19.50	N/A	i Rating by David Maris at Wells Fargo & Company
8/15/2016	Mizuho	Upgrade	Underperform ➝ Neutral	$25.00	N/A	i Rating by Irina Rivkind Koffler at Mizuho
8/13/2016	TD Securities	Reiterated Rating	Buy	$38.00	N/A	i Rating by Lennox Gibbs at TD Securities
8/11/2016	Mizuho	Upgrade	Underperform ➝ Neutral	$25.00	N/A	i Rating by Irina Rivkind Koffler at Mizuho
8/11/2016	Guggenheim	Reiterated Rating	Buy	$55.00	N/A	i Rating by Louise Chen at Guggenheim
8/11/2016	Royal Bank of Canada	Reiterated Rating	Sector Perform	$31.00	N/A	i
8/10/2016	Wells Fargo & Company	Reiterated Rating	Underperform	$19.50	N/A	i Rating by David Maris at Wells Fargo & Company
8/10/2016	Canaccord Genuity	Reiterated Rating	Hold	$28.00	N/A	i Rating by Neil Maruoka at Canaccord Genuity
8/10/2016	BTIG Research	Reiterated Rating	Neutral		N/A	i Rating by Tim Chiang at BTIG Research
8/10/2016	Jefferies Financial Group	Reiterated Rating	Buy	$40.00	N/A	i Rating by David Steinberg at Jefferies Financial Group Inc.
8/10/2016	Piper Jaffray Companies	Boost Price Target	Underweight	$19.00 ➝ $22.00	N/A	i Rating by David Amsellem at Piper Jaffray Companies
8/10/2016	Royal Bank of Canada	Boost Price Target	Sector Perform	$31.00 ➝ $36.00	N/A	i Rating by Douglas Miehm at Royal Bank of Canada
8/9/2016	Rodman & Renshaw	Lower Price Target	Buy	$90.00 ➝ $81.00	N/A	i Rating by Ram Selvaraju at Rodman & Renshaw
8/3/2016	Morgan Stanley	Set Price Target	Hold	$33.00	N/A	i Rating by David Risinger at Morgan Stanley
8/1/2016	Canaccord Genuity	Reiterated Rating	Hold	$28.00	N/A	i Rating by Neil Maruoka at Canaccord Genuity
8/1/2016	Wells Fargo & Company	Reiterated Rating	Underperform	$19.50	N/A	i Rating by David Maris at Wells Fargo & Company
7/28/2016	Rodman & Renshaw	Reiterated Rating	Buy	$90.00	N/A	i Rating by Ram Selvaraju at Rodman & Renshaw
7/26/2016	Scotiabank	Reiterated Rating	Sector Perform	$35.00 ➝ $32.00	N/A	i
7/26/2016	Mizuho	Reiterated Rating	Underperform	$11.00	N/A	i Rating by Irina Rivkind Koffler at Mizuho
7/25/2016	JPMorgan Chase & Co.	Set Price Target	Hold	$35.00	N/A	i Rating by Chris Schott at JPMorgan Chase & Co.
7/20/2016	BMO Capital Markets	Reiterated Rating	Market Perform	$26.00	N/A	i Rating by Alex Arfaei at BMO Capital Markets
7/19/2016	Royal Bank of Canada	Reiterated Rating	Sector Perform	$33.00	N/A	i
7/18/2016	Canaccord Genuity	Reiterated Rating	Hold	$28.00	N/A	i Rating by Neil Maruoka at Canaccord Genuity
7/17/2016	TD Securities	Reiterated Rating	Hold	$38.00	N/A	i Rating by Lennox Gibbs at TD Securities
7/17/2016	Mizuho	Reiterated Rating	Underperform		N/A	i Rating by Irina Rivkind Koffler at Mizuho
7/17/2016	Wells Fargo & Company	Reiterated Rating	Sell	$19.50	N/A	i Rating by David Maris at Wells Fargo & Company
7/17/2016	Rodman & Renshaw	Reiterated Rating	Buy	$90.00	N/A	i Rating by Ram Selvaraju at Rodman & Renshaw
7/6/2016	Rodman & Renshaw	Reiterated Rating	Buy	$90.00	N/A	i Rating by Ram Selvaraju at Rodman & Renshaw
7/6/2016	Stifel Nicolaus	Reiterated Rating	Buy	$55.00	N/A	i Rating by Annabel Samimy at Stifel Nicolaus
6/29/2016	Wells Fargo & Company	Reiterated Rating	Sell		N/A	i Rating by David Maris at Wells Fargo & Company
6/28/2016	BMO Capital Markets	Initiated Coverage	Market Perform	$26.00	N/A	i Rating by Alex Arfaei at BMO Capital Markets
6/27/2016	Royal Bank of Canada	Reiterated Rating	Sector Perform		N/A	i Rating by Douglas Miehm at Royal Bank of Canada
6/22/2016	JPMorgan Chase & Co.	Reiterated Rating	Overweight ➝ Hold	$50.00 ➝ $35.00	N/A	i Rating by Reiterated, Yesterday Hold at JPMorgan Chase & Co.
6/20/2016	Wells Fargo & Company	Reiterated Rating	Sell		N/A	i Rating by David Maris at Wells Fargo & Company
6/16/2016	Royal Bank of Canada	Reiterated Rating	Hold	$33.00	N/A	i Rating by Douglas Miehm at Royal Bank of Canada

(Data available from 6/16/2016 forward)

Bausch Health Companies Inc. develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through four segments: Bausch + Lomb/International, Salix, Ortho Dermatologics, and Diversified Products. The Bausch + Lomb/International segment offers products with a focus on the vision care, surgical, and consumer and ophthalmology Rx products in the United States; and Solta products, branded and generic pharmaceutical products, OTC products, and medical device products, and Bausch + Lomb products in Canada, Europe, Asia, Australia, Latin America, Africa, and the Middle East. The Salix segment provides gastroenterology products in the United States. The Ortho Dermatologics segment offers dermatological products in the United States; and Solta medical aesthetic devices internationally. The Diversified Products segment provides pharmaceutical products in the areas of neurology and other therapeutic classes, as well as generic and dentistry products in the United States. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.

Today's Range

Now: $29.91

$29.74

$30.90

50 Day Range

MA: $30.41

$27.43

$32.70

52 Week Range

Now: $29.91

$14.86

$34.80

Volume

3,285,778 shs

Average Volume

4,021,123 shs

Market Capitalization

$10.72 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.74

Frequently Asked Questions

What sell-side analysts currently cover shares of Bausch Health Companies?

The following Wall Street analysts have issued research reports on Bausch Health Companies in the last year: Bank of America Co., Barclays PLC, Citigroup Inc., HC Wainwright, Jefferies Financial Group Inc., JPMorgan Chase & Co., Morgan Stanley, Piper Sandler, Royal Bank of Canada, TheStreet, Wells Fargo & Company, and Zacks Investment Research.
View the latest analyst ratings for BHC.

What is the current price target for Bausch Health Companies?

10 Wall Street analysts have set twelve-month price targets for Bausch Health Companies in the last year. Their average twelve-month price target is $34.80, suggesting a possible upside of 16.3%. HC Wainwright has the highest price target set, predicting BHC will reach $55.00 in the next twelve months. Wells Fargo & Company has the lowest price target set, forecasting a price of $17.00 for Bausch Health Companies in the next year.
View the latest price targets for BHC.

What is the current consensus analyst rating for Bausch Health Companies?

Bausch Health Companies currently has 1 sell rating, 3 hold ratings and 5 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in BHC, but not buy more shares or sell existing shares.
View the latest ratings for BHC.

What other companies compete with Bausch Health Companies?

Other companies that are similar to Bausch Health Companies include Alexion Pharmaceuticals, Astellas Pharma, BeiGene, Shiseido, Genmab A/S, Takeda Pharmaceutical, Genmab A/S, Royalty Pharma, MERCK Kommanditgesellschaft auf Aktien, Horizon Therapeutics Public, Alnylam Pharmaceuticals, Catalent, Viatris, CureVac and UCB.

How do I contact Bausch Health Companies' investor relations team?

Bausch Health Companies' physical mailing address is 2150 ST. ELZEAR BLVD. WEST, LAVAL A8, H7L 4A8. The company's listed phone number is 514-744-6792 and its investor relations email address is [email protected] The official website for Bausch Health Companies is www.bauschhealth.com.